The findings of the currently ongoing study assessing inhaled sGC stimulator use in PH due to COPD may also provide further evidence on the efficacy and safety of inhaled therapies targeting nitric oxide pathway (78). The gene discussed is SGCB; the disease is chronic obstructive pulmonary disease.